Titel: 12th Annual Bioethics Conference - The Changing Healthcare Landscape: Ethical Choices, Scientific Promises, and the Quality of Life
Beginn:
23.9.2005
Veranstaltungsort:
One Constitution Square
New Brunswick, NJ 08901
Weitere Informationen:
http://www.njhealthdecisions.org/njhd_12.pdf
of new developments. The bioethics landscape has undergone a dramatic change since the Terri Schiavo case. Patients, families, and healthcare providers look to the law to set clear rules, though they may have different interpretations of where these boundaries should be. Our conference will address evolving issues in bioethics and healthcare, which currently confound and occasionally divide us. Well recognized leaders from
medicine, law, and ethics will address significant concerns arising from new
understandings of what having a regard for life means, and propose resolutions which will be of future importance at the bedside.
The program will set an ethical framework to explore areas of concern. Hard-won rights for competent adults to refuse medical treatment, established over 30 years from Quinlan to Cruzan, have now been called into question. New research on brain function has generated controversies over the withdrawal or withholding of life-sustaining treatment
for those in permanent vegetative or minimally conscious states. Fears about how successful stem cell therapies might change the contours of human life and encourage us to see human embryos as material to be manipulated have made many fearful and left them questioning how we should define human life, uniqueness, and dignity. Furthermore, we are challenged by considerations of social justice in meeting the healthcare needs of the elderly, people with disabilities, and the uninsured, and deciding just how much scientific progress our society can truly afford.
In an era where diverse religious values, the right to self-determination, social justice and rapidly advancing scientific technologies play prominent roles, it is vital that healthcare
professionals understand the issues to produce better patient outcomes.
CONFERENCE OBJECTIVES
After attending this conference, participants should be able to:
Explore the limits of the law in end-of-life care, new proposals for the use of advance directives, and the role of family in healthcare decisions;
Identify new data and its implications for treatment of patients in permanent
vegetative or minimally conscious states;
Examine the new claims for medical futility and the integration of palliative care into advance care plans;
Examine ethical dilemmas surrounding the use of stem cell and embryonic
research; and
Prioritize societys healthcare needs and the growing conflict between efforts to limit medical spending and insistence on all possible beneficial care.
Kontakt:
Mrs. Minerva Bozzone
New Jersey Health Decisions
13 Rockland Terrace
Verona, NJ 07044
Tel.: +1 - (0)973 - 8 57 55 52
Fax: +1 - (0)973 - 8 57 80 83
njhd@verizon.net; mebozzone@verizon.net
http://www.njhealthdecisions.org/
Veranstalter: New Jersey Health Decisions
Schlagworte: Behinderung, Embryonale Stammzellen, Embryonenforschung, Gesundheitswesen, Lebensende, Palliativbehandlung